Panbela Therapeutics Inc (PBLA)
0.3813
-0.03
(-7.00%)
USD |
OTCM |
May 02, 16:00
Panbela Therapeutics Shareholders Equity (Quarterly): -4.71M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.71M |
| September 30, 2023 | -2.483M |
| June 30, 2023 | 4.802M |
| March 31, 2023 | 2.535M |
| December 31, 2022 | -8.049M |
| September 30, 2022 | -8.279M |
| June 30, 2022 | -4.838M |
| March 31, 2022 | 6.581M |
| December 31, 2021 | 10.21M |
| September 30, 2021 | 13.46M |
| June 30, 2021 | 5.902M |
| March 31, 2021 | 7.584M |
| December 31, 2020 | 8.448M |
| September 30, 2020 | 9.549M |
| June 30, 2020 | 1.60M |
| March 31, 2020 | 0.724M |
| December 31, 2019 | 1.385M |
| September 30, 2019 | 2.389M |
| June 30, 2019 | -0.117M |
| March 31, 2019 | -0.588M |
| December 31, 2018 | 0.268M |
| September 30, 2018 | -0.542M |
| June 30, 2018 | 0.11M |
| Date | Value |
|---|---|
| March 31, 2018 | -2.32M |
| December 31, 2017 | -3.689M |
| September 30, 2017 | -2.099M |
| June 30, 2017 | -0.955M |
| March 31, 2017 | 0.338M |
| December 31, 2016 | -4.642M |
| September 30, 2016 | -3.505M |
| June 30, 2016 | -2.639M |
| March 31, 2016 | -3.505M |
| December 31, 2015 | -2.681M |
| September 30, 2015 | -1.989M |
| June 30, 2015 | -0.3721M |
| March 31, 2015 | -0.2903M |
| December 31, 2014 | -1.316M |
| September 30, 2014 | -0.376M |
| June 30, 2014 | -0.2888M |
| March 31, 2014 | -0.24M |
| December 31, 2013 | -0.1379M |
| September 30, 2013 | -0.1267M |
| June 30, 2013 | -0.0913M |
| March 31, 2013 | -0.0861M |
| December 31, 2012 | -0.0408M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.279M
Minimum
Sep 2022
13.46M
Maximum
Sep 2021
2.458M
Average
2.389M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
| Processa Pharmaceuticals Inc | 4.989M |
| Fate Therapeutics Inc | 368.42M |
| Ardelyx Inc | 166.82M |
| Checkpoint Therapeutics Inc | -13.05M |
| Palisade Bio Inc | 11.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.80M |
| Total Liabilities (Quarterly) | 16.51M |